LTR Pharma (ASX:LTP) Accounts Payable & Accrued Expense : A$0.01 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Accounts Payable & Accrued Expense?

LTR Pharma's quarterly accounts payable & accrued expense increased from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.47 Mil) but then declined from Jun. 2022 (A$0.47 Mil) to Jun. 2023 (A$0.01 Mil).

LTR Pharma's annual accounts payable & accrued expense increased from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.47 Mil) but then declined from Jun. 2022 (A$0.47 Mil) to Jun. 2023 (A$0.01 Mil).

LTR Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for LTR Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Accounts Payable & Accrued Expense Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

0.47

0.01

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Accounts Payable & Accrued Expense	-	0.47	0.01

LTR Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines